Company Details
parexel
20,434
831,540
3254
parexel.com
0
PAR_1325249
In-progress


Parexel Vendor Cyber Rating & Cyber Score
parexel.comParexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.
Company Details
parexel
20,434
831,540
3254
parexel.com
0
PAR_1325249
In-progress
Between 750 and 799

Parexel Global Score (TPRM)XXXX

Description: Parexel Reports Data Breach Impacting Sensitive Employee Information Parexel, a global clinical research organization, disclosed a data breach affecting sensitive personal information stored in its Oracle OCI E-Business Suite (Oracle EBS) environment. On October 4, 2025, the company detected suspicious activity within the system, prompting an investigation. The breach, confirmed through forensic analysis, revealed that an unauthorized third party accessed employee-related data. Exposed information may include names, Social Security numbers, dates of birth, financial account numbers, payment card details (excluding CVVs), and national ID numbers, though the exact data varies by individual. On December 17, 2025, Parexel began notifying affected individuals via mail, detailing the compromised information and offering 24 months of complimentary credit monitoring services. The breach notice was filed with the Attorney General of Massachusetts, where impacted residents were among the first to be informed. The full scope of affected individuals and additional details remain under review.


No incidents recorded for Parexel in 2026.
No incidents recorded for Parexel in 2026.
No incidents recorded for Parexel in 2026.
Parexel cyber incidents detection timeline including parent company and subsidiaries

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.


Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccine

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro
.png)
YourStory GCC Summit 2025 recognised GCCs and individuals who made outstanding contributions to putting the Indian tech landscape on the...
Exabeam, a global cybersecurity leader that delivers AI-driven security operations, today announced the appointment of Mike Byron as Chief Financial Officer (...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Parexel is http://www.parexel.com.
According to Rankiteo, Parexel’s AI-generated cybersecurity score is 794, reflecting their Fair security posture.
According to Rankiteo, Parexel currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Parexel has been affected by a supply chain cyber incident involving Oracle, with the incident ID ORAPAR1766015901.
According to Rankiteo, Parexel is not certified under SOC 2 Type 1.
According to Rankiteo, Parexel does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Parexel is not listed as GDPR compliant.
According to Rankiteo, Parexel does not currently maintain PCI DSS compliance.
According to Rankiteo, Parexel is not compliant with HIPAA regulations.
According to Rankiteo,Parexel is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Parexel operates primarily in the Pharmaceutical Manufacturing industry.
Parexel employs approximately 20,434 people worldwide.
Parexel presently has no subsidiaries across any sectors.
Parexel’s official LinkedIn profile has approximately 831,540 followers.
Parexel is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, Parexel does not have a profile on Crunchbase.
Yes, Parexel maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/parexel.
As of April 04, 2026, Rankiteo reports that Parexel has experienced 1 cybersecurity incidents.
Parexel has an estimated 5,608 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability.
Detection and Response: The company detects and responds to cybersecurity incidents through an communication strategy with data breach notification letters mailed to impacted individuals..
Title: Parexel Data Breach Involving Sensitive Personal Information
Description: Parexel reported a data breach where sensitive personal identifiable information in its Oracle OCI E-Business Suite environment may have been compromised. An unauthorized third party accessed the data, leading to the exposure of personal and financial information of employees.
Date Detected: 2025-10-04
Date Publicly Disclosed: 2025-12-17
Type: Data Breach
Threat Actor: Unauthorized third party
Common Attack Types: The most common types of attacks the company has faced is Vulnerability.

Data Compromised: Sensitive personal identifiable information
Systems Affected: Oracle OCI E-Business Suite (Oracle EBS)
Identity Theft Risk: High
Payment Information Risk: High
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Name, Social Security Number, Date Of Birth, Financial Account Number, Payment Card Number (Without Cvv), National Id Number and .

Entity Name: Parexel
Entity Type: Company
Industry: Clinical Research, Pharmaceutical
Customers Affected: Employees

Communication Strategy: Data breach notification letters mailed to impacted individuals

Type of Data Compromised: Name, Social security number, Date of birth, Financial account number, Payment card number (without cvv), National id number
Sensitivity of Data: High
Personally Identifiable Information: Yes

Regulatory Notifications: Reported to the Attorney General of the Commonwealth of Massachusetts

Source: Attorney General of the Commonwealth of Massachusetts
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: Attorney General of the Commonwealth of Massachusetts.

Investigation Status: Completed
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through Data breach notification letters mailed to impacted individuals.

Customer Advisories: 24 months of complimentary credit monitoring services provided to affected individuals
Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: was 24 months of complimentary credit monitoring services provided to affected individuals.
Last Attacking Group: The attacking group in the last incident was an Unauthorized third party.
Most Recent Incident Detected: The most recent incident detected was on 2025-10-04.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2025-12-17.
Most Significant Data Compromised: The most significant data compromised in an incident was Sensitive personal identifiable information.
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was Sensitive personal identifiable information.
Most Recent Source: The most recent source of information about an incident is Attorney General of the Commonwealth of Massachusetts.
Current Status of Most Recent Investigation: The current status of the most recent investigation is Completed.
Most Recent Customer Advisory: The most recent customer advisory issued was an 24 months of complimentary credit monitoring services provided to affected individuals.
.png)
nimiq/core-rs-albatross is a Rust implementation of the Nimiq Proof-of-Stake protocol based on the Albatross consensus algorithm. Prior to version 1.3.0, two peer-facing consensus request handlers assume that the history index is always available and call blockchain.history_store.history_index().unwrap() directly. That assumption is false by construction. HistoryStoreProxy::history_index() explicitly returns None for the valid HistoryStoreProxy::WithoutIndex state. when a full node is syncing or otherwise running without the history index, a remote peer can send RequestTransactionsProof or RequestTransactionReceiptsByAddress and trigger an Option::unwrap() panic on the request path. This issue has been patched in version 1.3.0.
PraisonAI is a multi-agent teams system. Prior to version 1.5.95, FileTools.download_file() in praisonaiagents validates the destination path but performs no validation on the url parameter, passing it directly to httpx.stream() with follow_redirects=True. An attacker who controls the URL can reach any host accessible from the server including cloud metadata services and internal network services. This issue has been patched in version 1.5.95.
PraisonAI is a multi-agent teams system. Prior to version 4.5.97, OAuthManager.validate_token() returns True for any token not found in its internal store, which is empty by default. Any HTTP request to the MCP server with an arbitrary Bearer token is treated as authenticated, granting full access to all registered tools and agent capabilities. This issue has been patched in version 4.5.97.
PraisonAI is a multi-agent teams system. Prior to version 4.5.97, the PraisonAI Gateway server accepts WebSocket connections at /ws and serves agent topology at /info with no authentication. Any network client can connect, enumerate registered agents, and send arbitrary messages to agents and their tool sets. This issue has been patched in version 4.5.97.
PraisonAI is a multi-agent teams system. Prior to version 4.5.90, MCPToolIndex.search_tools() compiles a caller-supplied string directly as a Python regular expression with no validation, sanitization, or timeout. A crafted regex causes catastrophic backtracking in the re engine, blocking the Python thread for hundreds of seconds and causing a complete service outage. This issue has been patched in version 4.5.90.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.